Regenx Biosciences and Voyager Therapeutics Announce License Agreement
Industry News
FDA Awards Fast Track Status to Edison Pharmaceuticals’ EPI-743 for Friedreich’s Ataxia
Industry News
FDA Grants Edison Pharmaceuticals’ EPI-743 Orphan Status for Friedreich’s Ataxia
Industry News
Methodically Falling Prey
Ambassador